• Atherogenic Markers In Predicting Cardiovascular Risk And Targeting Residual Cardiovascular Risk 

      Catapano, A.L.; Tokgözoğlu, L.; Mello e Silva, A.; Bruckert, E. (2019)
      Low-density lipoprotein (LDL)cholesterol (LDL-C)is the primary target in cardiovascular (CV)disease prevention and is commonly used in estimating CV risk; however, alternative markers may be needed when LDL-C is not an ...
    • Kardiyak Amiloidoz: Tanı Ve Tedavide Yenilikler 

      Çavuşoğlu, Y.; Özpelit, E.; Çelik, A.; İkitimur, B.; Kayıkçıoğlu, M.; Tokgözoğlu, L.; Tüfekçioğlu, O.; Yılmaz, M.B. (2019)
      Cardiac amyloidosis (CA) is a progressive cardiomyopathy in which misfolded endogenous proteins form amyloid fibrils that deposit in the heart as well as kidneys, liver, gastrointestinal tract and soft tissues. The most ...
    • Pharmaceutical Strategies For Reducing Ldl-C And Risk Of Cardiovascular Disease 

      Catapano, A.L.; Tokgözoğlu, L.; Mello e Silva, A.; Bruckert, E. (2019)
      A key strategy in preventing cardiovascular (CV) disease is the reduction of low-density lipoprotein cholesterol (LDL-C). Statins are a crucial therapy for achieving LDL-C reductions, with the highest tolerated dose often ...